| Absorption |
| Blood-Brain Barrier | BBB+ | 0.5320 |
| Human Intestinal Absorption | HIA+ | 0.9872 |
| Caco-2 Permeability | Caco2+ | 0.8937 |
| P-glycoprotein Substrate | Non-substrate | 0.7493 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9890 |
| Non-inhibitor | 0.9927 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9078 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9063 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8115 |
| CYP450 2D6 Substrate | Non-substrate | 0.9377 |
| CYP450 3A4 Substrate | Non-substrate | 0.7652 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9752 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9697 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9827 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9651 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9493 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9554 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9617 |
| Non-inhibitor | 0.9771 |
| AMES Toxicity | Non AMES toxic | 0.9826 |
| Carcinogens | Non-carcinogens | 0.8226 |
| Fish Toxicity | High FHMT | 0.7616 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8365 |
| Honey Bee Toxicity | High HBT | 0.7797 |
| Biodegradation | Ready biodegradable | 0.8413 |
| Acute Oral Toxicity | III | 0.5472 |
| Carcinogenicity (Three-class) | Non-required | 0.6300 |